The DOI matches its Crossref record; 472 of the 472 references it cites were found in a registry or an index.
Dopamine: Functions, Signaling, and Association with Neurological Diseases
Open accessAbstract
The dopaminergic system plays important roles in neuromodulation, such as motor control, motivation, reward, cognitive function, maternal, and reproductive behaviors. Dopamine is a neurotransmitter, synthesized in both central nervous system and the periphery, that exerts its actions upon binding to G protein-coupled receptors. Dopamine receptors are widely expressed in the body and function in both the peripheral and the central nervous systems. Dopaminergic signaling pathways are crucial to the maintenance of physiological processes and an unbalanced activity may lead to dysfunctions that are related to neurodegenerative diseases. Unveiling the neurobiology and the molecular mechanisms that underlie these illnesses may contribute to the development of new therapies that could promote a better quality of life for patients worldwide. In this review, we summarize the aspects of dopamine as a catecholaminergic neurotransmitter and discuss dopamine signaling pathways elicited through dopamine receptor activation in normal brain function. Furthermore, we describe the potential involvement of these signaling pathways in evoking the onset and progression of some diseases in the nervous system, such as Parkinson's, Schizophrenia, Huntington's, Attention Deficit and Hyperactivity Disorder, and Addiction. A brief description of new dopaminergic drugs recently approved and under development treatments for these ailments is also provided.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“An extensive literature implicates shared alterations in the reward circuitry in MDD, neurodegenerative disorders, and obesity261-263.”
From Comorbidity between major depressive disorder and physical diseases: a comprehensive review of epidemiology, mechanisms and management (2023) · cites this paper as [263]
In the citing paper
“One of the reasons that hinder the diagnosis and treatment of this disorder is the lack of complete understanding of the underlying molecular pathology [16].”
From Molecular Characterisation of the Mechanism of Action of Stimulant Drugs Lisdexamfetamine and Methylphenidate on ADHD Neurobiology: A Review (2022) · cites this paper as [16]
In the citing paper
“DA plays an essential role in mediating regulation of the cortical system, memory, mood, vascular structure, anticipation of events, motivation, behaviour inhibition, decision-making and problem-solving [16, 81, 82].”
From Molecular Characterisation of the Mechanism of Action of Stimulant Drugs Lisdexamfetamine and Methylphenidate on ADHD Neurobiology: A Review (2022) · cites this paper as [16]
Citations
Cites
Items 201–400 of 472
Roles of the Akt/GSK-3 and Wnt Signaling Pathways in Schizophrenia and Antipsychotic Drug Action
Freyberg, Z., Ferrando, S. J., & Javitch, J. A. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.08121873 · Cited by 288
The glutamate hypothesis of schizophrenia: evidence from human brain tissue studies
Hu, W., MacDonald, M. L., Elswick, D. E., & Sweet, R. A. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12547 · Cited by 286
The dopaminergic mesencephalic projections to the hippocampal formation in the rat
Gasbarri, A., Sulli, A., & Packard, M. G. (1997) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(96)00157-1 · Cited by 285
Carli, M., Evenden, J. L., & Robbins, T. W. (1985) · Nature · doi:10.1038/313679a0 · Cited by 284
Neurotransmitter Corelease: Mechanism and Physiological Role
Hnasko, T. S., & Edwards, R. H. (2012) · Annual Review of Physiology · doi:10.1146/annurev-physiol-020911-153315 · Cited by 284
Bertorello, A. M., Hopfield, J. F., Aperia, A. C., & Greengard, P. (1990) · Nature · doi:10.1038/347386a0 · Cited by 282
Regulation of the Release of Coexisting Neurotransmitters
Bartfai, T., Iverfeldt, K., Fisone, G., & Serfözö, P. D. (1988) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.28.040188.001441 · Cited by 282
Venton, B. J., Zhang, H., Garris, P. A., Phillips, P. E. M., Sulzer, D., & Wightman, R. M. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02109.x · Cited by 281
Regulation of Akt Signaling by D2and D3Dopamine ReceptorsIn Vivo
Beaulieu, J., Tirotta, E., Sotnikova, T. D., Masri, B., Salahpour, A., Gainetdinov, R. R., Borrelli, E., & Caron, M. G. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.5074-06.2007 · Cited by 275
Periodic limb movements in sleep: State-dependent excitability of the spinal flexor reflex
Nogués, M. A., Pardal, A., Barroso, F. A., & Gonzalez, J. V. (2000) · Neurology · doi:10.1212/wnl.55.8.1243 · Cited by 273
Yan, Z., Song, W., & Surmeier, D. J. (1997) · Journal of Neurophysiology · doi:10.1152/jn.1997.77.2.1003 · Cited by 273
Ralph, R. J., Paulus, M. P., Fumagalli, F., Caron, M. G., & Geyer, M. A. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-01-00305.2001 · Cited by 271
Dopamine dysregulation of movement control in l-DOPA-induced dyskinesia
Cenci, M. A. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.03.005 · Cited by 270
Periodic limb movements in sleep
Bara‐Jimenez, W., Aksu, M., Graham, B., Sato, S., & Hallett, M. (2000) · Neurology · doi:10.1212/wnl.54.8.1609 · Cited by 269
Luciana, M. M. (1998) · Cerebral Cortex · doi:10.1093/cercor/8.3.218 · Cited by 265
Ahn, S., Maudsley, S. R., Luttrell, L. M., Lefkowitz, R. J., & Daaka, Y. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.3.1185 · Cited by 263
Origin and termination of the diencephalo-spinal dopamine system in the rat
Skagerberg, G., Björklund, A., Lindvall, O., & Schmidt, R. H. (1982) · Brain Research Bulletin · doi:10.1016/0361-9230(82)90136-8 · Cited by 262
Dopamine Secretion Is Mediated by Sparse Active Zone-like Release Sites
Liu, C., Kershberg, L., Wang, J., Schneeberger, S., & Kaeser, P. S. (2018) · Cell · doi:10.1016/j.cell.2018.01.008 · Cited by 256
Cross sectional prevalence survey of idiopathic Parkinson's disease and parkinsonism in London
Schrag, A. E., Ben‐Shlomo, Y., & Quinn, N. P. (2000) · BMJ · doi:10.1136/bmj.321.7252.21 · Cited by 255
Activation of heterologously expressed D3 dopamine receptors: comparison with D2 dopamine receptors.
Chio, C. L., Lajiness, M. E., & Huff, R. M. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09903-1 · Cited by 255
Ugi, S., Imamura, T., Maegawa, H., Egawa, K., Yoshizaki, T., Shi, K., Obata, T., Ebina, Y., Kashiwagi, A., & Olefsky, J. M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.19.8778-8789.2004 · Cited by 252
Molecular pathogenesis of Parkinson's disease
Gandhi, S., & Wood, N. W. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi308 · Cited by 251
Intrarenal Dopamine: A Key Signal in the Interactive Regulation of Sodium Metabolism
Aperia, A. C. (2000) · Annual Review of Physiology · doi:10.1146/annurev.physiol.62.1.621 · Cited by 244
Neurodevelopment, GABA System Dysfunction, and Schizophrenia
Schmidt, M. J., & Mirnics, K. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.95 · Cited by 243
Cytochrome P450 enzymes in the brain: emerging evidence of biological significance
Ferguson, C. S., & Tyndale, R. F. (2011) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2011.08.005 · Cited by 241
Jones, C. K., Byun, N. E., & Bubser, M. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.199 · Cited by 241
A phosphatase cascade by which rewarding stimuli control nucleosomal response
Stipanovich, A., Valjent, E., Matamales, M., Nishi, A., Ahn, J., Maroteaux, M. J., Bertran‐Gonzalez, J., Brami‐Cherrier, K., Enslen, H., Corbillé, A.-G., et al. (2008) · Nature · doi:10.1038/nature06994 · Cited by 237
Stolerman, I. P., & Price, L. H. (2015) · Springer eBooks · doi:10.1007/978-3-642-36172-2_200188 · Cited by 234
Cell type–specific regulation of DARPP-32 phosphorylation by psychostimulant and antipsychotic drugs
Bateup, H. S., Svenningsson, P., Kuroiwa, M., Gong, S., Nishi, A., Heintz, N., & Greengard, P. (2008) · Nature Neuroscience · doi:10.1038/nn.2153 · Cited by 233
Foster, D. J., & Conn, P. J. (2017) · Neuron · doi:10.1016/j.neuron.2017.03.016 · Cited by 231
Dopaminergic Supersensitivity in G Protein-Coupled Receptor Kinase 6-Deficient Mice
Gainetdinov, R. R., Bohn, L., Sotnikova, T. D., Cyr, M., Laakso, A., Macrae, A. D., Torres, G. E., Kim, K.-M., Lefkowitz, R. J., Caron, M. G., et al. (2003) · Neuron · doi:10.1016/s0896-6273(03)00192-2 · Cited by 229
Fallon, J. H., & Moore, R. Y. (1978) · The Journal of Comparative Neurology · doi:10.1002/cne.901800309 · Cited by 226
Magnusson, J. E., & Fisher, K. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02396-3 · Cited by 223
Getting specialized: presynaptic and postsynaptic dopamine D2 receptors
Mei, C. D., Ramos, M., Iitaka, C., & Borrelli, E. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2008.12.002 · Cited by 220
Dopamine receptor binding in the corpus striatum of mammalian brain.
Burt, D. R., Enna, S. J., Creese, I., & Snyder, S. H. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.11.4655 · Cited by 220
Numan, M., & Smith, H. G. (1984) · Behavioral Neuroscience · doi:10.1037//0735-7044.98.4.712 · Cited by 215
Eiden, L. E., Sch�fer, M. K.-H., Weihe, E., & tz, B. S. (2004) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-003-1100-5 · Cited by 213
Anlauf, M., Schäfer, M. K.-H., Eiden, L. E., & Weihe, E. (2003) · The Journal of Comparative Neurology · doi:10.1002/cne.10599 · Cited by 213
Takano, H., Cancel‐Tassin, G., Ikeuchi, T., Lorenzetti, D., Mawad, R., Stévanin, G., Didierjean, O., Dürr, A., Oyake, M., Shimohata, T., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/302067 · Cited by 212
Protective Actions of the Vesicular Monoamine Transporter 2 (VMAT2) in Monoaminergic Neurons
Guillot, T. S., & Miller, G. W. (2009) · Molecular Neurobiology · doi:10.1007/s12035-009-8059-y · Cited by 209
Gresch, P. J., Sved, A. F., Zigmond, M. J., & Finlay, J. M. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65010111.x · Cited by 208
Dopaminergic Signaling and Striatal Neurodegeneration in Huntington's Disease
Tang, T.-S., Chen, X., Liu, J., & Борисович, Б. И. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.1396-07.2007 · Cited by 207
The Evoked Heart Rate Response to Periodic Leg Movements of Sleep
Winkelman, J. W. (1999) · SLEEP · doi:10.1093/sleep/22.5.575 · Cited by 207
Floresco, S. B., & Tse, M. T. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.5474-06.2007 · Cited by 204
Photoreceptors of mouse retinas possess D4 receptors coupled to adenylate cyclase.
Cohen, A. I., Todd, R. D., Harmon, S. K., & O’Malley, K. L. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.12093 · Cited by 202
Signaling mediated by the dopamine D2 receptor potentiates circadian regulation by CLOCK:BMAL1
Yujnovsky, I., Hirayama, J., Doi, M., Borrelli, E., & Sassone‐Corsi, P. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510691103 · Cited by 201
Effects of tyrosine hydroxylase inhibition on the amine levels of central monoamine neurons
Andén, N., CORRODI, H., Dahlström, A. B., Fuxé, K., & Hökfelt, T. G. M. (1966) · Life Sciences · doi:10.1016/0024-3205(66)90177-9 · Cited by 201
Neuronal cell death in Huntington’s disease: a potential role for dopamine
Jakel, R. J., & Maragos, W. F. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01568-x · Cited by 199
Functional Interaction between Trace Amine-Associated Receptor 1 and Dopamine D2 Receptor
Espinoza, S., Salahpour, A., Masri, B., Sotnikova, T. D., Messa, M., Barak, L. S., Caron, M. G., & Gainetdinov, R. R. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.073304 · Cited by 199
Mammalian brain phosphoproteins as substrates for calcineurin.
King, M. M., Huang, C., Chock, P. B., Nairn, A. C., Hemmings, H. C., Chan, K.-F. J., & Greengard, P. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)39694-1 · Cited by 198
Cognitive heterogeneity in schizophrenia
Joyce, E. M., & Roiser, J. P. (2007) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e3280ba4975 · Cited by 198
VMAT2: a dynamic regulator of brain monoaminergic neuronal function interacting with drugs of abuse
Eiden, L. E., & Weihe, E. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05906.x · Cited by 197
Arriza, J. L., Dawson, T., Simerly, R. B., Martin, L., Caron, M. G., Snyder, S. H., & Lefkowitz, R. J. (1992) · Journal of Neuroscience · doi:10.1523/jneurosci.12-10-04045.1992 · Cited by 195
Neuroanatomical Circuitry for Mammalian Maternal Behaviora
Numan, M., & Sheehan, T. P. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb51915.x · Cited by 194
Local control of striatal dopamine release
Cachope, R., & Cheer, J. F. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00188 · Cited by 191
Gudelsky, G. A., & Porter, J. C. (1980) · Endocrinology · doi:10.1210/endo-106-2-526 · Cited by 190
Numan, M., & Smith, H. G. (1984) · Behavioral Neuroscience · doi:10.1037/0735-7044.98.4.712 · Cited by 190
Dopamine in neurotoxicity and neuroprotection: what do D2 receptors have to do with it?
Bozzi, Y., & Borrelli, E. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.01.002 · Cited by 187
Numan, M., Numan, M. J., Pliakou, N., Stolzenberg, D. S., Mullins, O. J., Murphy, J. M., & Smith, C. D. (2005) · Behavioral Neuroscience · doi:10.1037/0735-7044.119.6.1588 · Cited by 186
G protein-coupled receptor kinases: Past, present and future
Komolov, K. E., & Benovic, J. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.07.004 · Cited by 185
Undie, A. S., Weinstock, J., Sarau, H. M., & Friedman, E. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62052045.x · Cited by 183
Willems, J., Buylaert, W. A., Lefebvre, R. A., & Bogaert, M. G. (1985) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06824-3 · Cited by 180
A Method for the Demonstration of Monoamine‐Containing Nerve Fibres in the Central Nervous System
Dahlström, A. B., & Fuxé, K. (1964) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1964.tb02891.x · Cited by 176
Tiberi, M., Nash, S. R., Bertrand, L., Lefkowitz, R. J., & Caron, M. G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.7.3771 · Cited by 174
Felder, C. C., José, P. A., & Axelrod, J. (1989) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23627-8 · Cited by 173
Dopamine signaling in food addiction: role of dopamine D2 receptors
Baik, J. (2013) · BMB Reports · doi:10.5483/bmbrep.2013.46.11.207 · Cited by 173
Phosphorylation of DARPP-32, a dopamine- and cAMP-regulated phosphoprotein, by casein kinase II
Girault, J., Hemmings, H. C., Williams, K. R., Nairn, A. C., & Greengard, P. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)88248-9 · Cited by 172
Heteromeric Dopamine Receptor Signaling Complexes: Emerging Neurobiology and Disease Relevance
Perreault, M. L., Hasbi, A., O’Dowd, B. F., & George, S. R. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.148 · Cited by 172
Kovoor, A., Seyffarth, P., Ebert, J., Barghshoon, S., Chen, C.-K., Schwarz, S. C., Axelrod, J. D., Cheyette, B. N. R., Simon, M. I., Lester, H. A., et al. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.2840-04.2005 · Cited by 171
The role of dopamine in huntington's disease
Cepeda, C., Murphy, K., Parent, M., & Levine, M. S. (2014) · Progress in brain research · doi:10.1016/b978-0-444-63425-2.00010-6 · Cited by 170
Dopamine-containing neurons in the spinal cord: Anatomy and some functional aspects
Lindvall, O., Björklund, A., & Skagerberg, G. (1983) · Annals of Neurology · doi:10.1002/ana.410140302 · Cited by 169
Brain structures and receptors involved in alertness
Aston‐Jones, G. (2005) · Sleep Medicine · doi:10.1016/s1389-9457(05)80002-4 · Cited by 168
Good night and good luck: Norepinephrine in sleep pharmacology
Mitchell, H. A., & Weinshenker, D. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.10.004 · Cited by 168
Comparison of the distribution of D-1 and D-2 dopamine receptors in the rat brain.
Wamsley, J. K., Gehlert, D. R., Filloux, F. M., & Dawson, T. M. (1989) · PubMed · Cited by 168
Beyond cAMP: the regulation of Akt and GSK3 by dopamine receptors
Beaulieu, J. (2011) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2011.00038 · Cited by 165
Precursors of adrenal epinephrine and norepinephrine in vivo
Udenfriend, S., & Wyngaarden, J. Β. (1956) · Biochimica et Biophysica Acta · doi:10.1016/0006-3002(56)90261-x · Cited by 163
Electrophysiology of dopamine in normal and denervated striatal neurons
Calabresi, P., Centonze, D., & Bernardi, G. (2000) · Trends in Neurosciences · doi:10.1016/s1471-1931(00)00017-3 · Cited by 163
Hansen, S., Harthon, C., Wallin, E., Löfberg, L., & Svensson, K. A. (1991) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(91)90399-m · Cited by 156
Interactions between Prolactin and Dopaminergic Neurons1
Moore, K. E. (1987) · Biology of Reproduction · doi:10.1095/biolreprod36.1.47 · Cited by 156
Kebabian, J. W. (1978) · Life Sciences · doi:10.1016/0024-3205(78)90157-1 · Cited by 154
In vivo imaging of synaptic function in the central nervous system
Nikolaus, S., Antke, C., & Müller, H. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.06.008 · Cited by 153
β-Arrestin/AP-2 Interaction in G Protein-coupled Receptor Internalization
Laporte, S. A., Miller, W. E., Kim, K.-M., & Caron, M. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108490200 · Cited by 153
G protein-coupled receptor kinases as regulators of dopamine receptor functions
Gurevich, E. V., Gainetdinov, R. R., & Gurevich, V. V. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.05.010 · Cited by 153
Fleming, A. S., Suh, E. J., Korsmit, M., & Rusak, B. (1994) · Behavioral Neuroscience · doi:10.1037/0735-7044.108.4.724 · Cited by 153
Phorbol-Ester Mediated Suppression of hASH1 Synthesis: Multiple Ways to Keep the Level Down
Benko, E., Winkelmann, A., Meier, J. C., Persson, P. B., Scholz, H., & Fähling, M. (2011) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2011.00001 · Cited by 150
Dopamine D1-Like Receptor Activation Excites Rat Striatal Large Aspiny NeuronsIn Vitro
Aosaki, T., Kiuchi, K., & Kawaguchi, Y. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-14-05180.1998 · Cited by 149
BASAL GANGLIA PATHOLOGY IN SCHIZOPHRENIA: DOPAMINE CONNECTIONS and ANOMALIES
Pérez‐Costas, E., Meléndez‐Ferro, M., & Roberts, R. C. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06604.x · Cited by 149
Trace Amine-Associated Receptor 1 Is a Modulator of the Dopamine Transporter
Xie, Z., & Miller, G. M. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.117382 · Cited by 147
Hemmings, H. C., Nairn, A. C., & Greengard, P. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42626-3 · Cited by 143
Prolactinergic and dopaminergic mechanisms underlying sexual arousal and orgasm in humans
Krüger, T. H. C., Hartmann, U. H., & Schedlowski, M. (2005) · World Journal of Urology · doi:10.1007/s00345-004-0496-7 · Cited by 142
Mogenson, G. J., & Nielsen, M. A. (1984) · Behavioral and Neural Biology · doi:10.1016/s0163-1047(84)90424-2 · Cited by 141
Bruno Giros, A., Martres, M., Pilon, C., Sokoloff, P., & Schwartz, J.-C. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)90469-n · Cited by 138
On the Origin of Cortical Dopamine: Is it a Co-Transmitter in Noradrenergic Neurons?
Devoto, P., & Flore, G. (2006) · Current Neuropharmacology · doi:10.2174/157015906776359559 · Cited by 137
Neuroendocrine Regulation of Lactation and Milk Production
Crowley, W. R. (2014) · Comprehensive physiology · doi:10.1002/cphy.c140029 · Cited by 135
Frankel, J. S., & Schwartz, T. L. (2016) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125316672136 · Cited by 135
Projections of diencephalic dopamine neurons into the spinal cord in mice
Qu, S., Ondo, W. G., Zhang, X., Xie, W., Pan, T. H., & Le, W. D. (2005) · Experimental Brain Research · doi:10.1007/s00221-005-0075-1 · Cited by 134
Hansen, S. (1994) · Physiology & Behavior · doi:10.1016/0031-9384(94)90034-5 · Cited by 132
Introduction to Special Section on β-Arrestins
Lefkowitz, R. (2007) · Annual Review of Physiology · doi:10.1146/annurev.ph.69.013107.100021 · Cited by 132
Tuberoinfundibular dopamine neurons and the regulation of prolactin secretion
Gudelsky, G. A. (1981) · Psychoneuroendocrinology · doi:10.1016/0306-4530(81)90044-5 · Cited by 127
Late onset of Huntington's disease.
Myers, R. H., Sax, D. S., Schoenfeld, M., Bird, E. D., Wolf, P. A., Vonsattel, J. P., White, R. F., & Martin, J. B. (1985) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.48.6.530 · Cited by 127
Pascoli, V., Besnard, A., Hervé, D., Pagès, C., Heck, N., Girault, J., Caboche, J., & Vanhoutte, P. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.08.031 · Cited by 126
Beom, S., Cheong, D.-W., Torres, G. E., Caron, M. G., & Kim, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403899200 · Cited by 126
Effect of reproductive factors and postmenopausal hormone use on the risk of Parkinson disease
Popat, R. A., Eeden, S. K. V. D., Tanner, C. M., McGuire, V. M., BERNSTEIN, A. L., Bloch, D. A., Leimpeter, A. D., & Nelson, L. M. (2005) · Neurology · doi:10.1212/01.wnl.0000171344.87802.94 · Cited by 125
Paoletti, P., Vila, I., Rife, M. F., Lizcano, J. M., Alberch, J., & Ginés, S. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.3237-08.2008 · Cited by 125
New Concepts in Dopamine D2 Receptor Biased Signaling and Implications for Schizophrenia Therapy
Urs, N. M., Peterson, S. M., & Caron, M. G. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.10.011 · Cited by 124
Haloperidol-induced disruption of retrieval behavior and reversal with apomorphine in lactating rats
Giordano, A. L., Johnson, A. E., & Rosenblatt, J. S. (1990) · Physiology & Behavior · doi:10.1016/0031-9384(90)90288-f · Cited by 123
Clemens, S., & Hochman, S. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.3698-04.2004 · Cited by 122
Arriagada, C., Paris, I. B., Matas, M. J. S. D. L., Martinez-Alvarado, P., Cárdenas, S., Castañeda, P., Graumann, R., Perez-Pastene, C., Olea‐Azar, C., Couve, E., et al. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.03.014 · Cited by 122
Newman‐Tancredi, A., Nicolas, J., Audinot, V., Gavaudan, S., Verrièle, L., Touzard, M., Chaput, C., Richard, N., & Millan, M. J. (1998) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/pl00005243 · Cited by 121
Kambeitz, J. P., Abi‐Dargham, A., Kapur, S., & Howes, O. D. (2014) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.113.132308 · Cited by 120
Jicha, G. A., Berenfeld, B., & Davies, P. J. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19990315)55:6 · Cited by 119
Yokoyama, C., Okamura, H., Nakajima, T., Taguchi, J., & Ibata, Y. (1994) · The Journal of Comparative Neurology · doi:10.1002/cne.903440109 · Cited by 119
Murphy, J. A., Stein, I. S., Lau, C. G., Peixoto, R. T., Aman, T. K., Kaneko, N., Aromolaran, K. A., Saulnier, J. L., Popescu, G., Sabatini, B. L., et al. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.4538-13.2014 · Cited by 118
Liang, C., Nelson, O. L., Yazdani, U., Pasbakhsh, P., & German, D. C. (2004) · The Journal of Comparative Neurology · doi:10.1002/cne.20098 · Cited by 117
Ben-Zion, I., Tessler, R. J., Cohen, L., Lerer, E., Raz, Y., Bachner‐Melman, R., Gritsenko, I., Nemanov, L., Zohar, A. H., Belmaker, R. H., et al. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001832 · Cited by 117
So, C. H., Varghese, G. K., Curley, K. J., Kong, M. M. C., Alijaniaram, M., Ji, X., Nguyen, T., O’Dowd, B. F., & George, S. R. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.012229 · Cited by 116
Regulators of G Protein Signaling
Burchett, S. A. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0751335.x · Cited by 114
Nosrat, C. A., Ebendal, T., & Olson, L. (1996) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19961223)376:4 · Cited by 114
Intergenerational transmission of maternal behavior in rhesus macaques and its underlying mechanisms
Dario Maestripieri, A., Lindell, S. G., & Higley, J. D. (2007) · Developmental Psychobiology · doi:10.1002/dev.20200 · Cited by 110
Arrestin2 and arrestin3 are differentially expressed in the rat brain during postnatal development
Gurevich, E. V., Benovic, J., & Gurevich, V. V. (2002) · Neuroscience · doi:10.1016/s0306-4522(01)00511-5 · Cited by 110
So, C. H., Verma, V., Alijaniaram, M., Cheng, R., Rashid, A. J., O’Dowd, B. F., & George, S. R. (2009) · Molecular Pharmacology · doi:10.1124/mol.108.051805 · Cited by 110
D1 Dopamine Receptor Mediates Dopamine-induced Cytotoxicity via the ERK Signal Cascade
Chen, J., Rusnak, M., Luedtke, R. R., & Sidhu, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403891200 · Cited by 109
O’Brien, W. T., Huang, J. Y., Buccafusca, R., Garskof, J., Valvezan, A. J., Berry, G. T., & Klein, P. S. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45194 · Cited by 109
Kuzhikandathil, E. V., Yu, W., & Oxford, G. S. (1998) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1998.0722 · Cited by 109
Ha, A. D., & Fung, V. S. C. (2012) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3283550c97 · Cited by 108
Role of dopamine receptors in the kidney in the regulation of blood pressure
José, P. A., Eisner, G. M., & Felder, R. A. (2002) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200201000-00013 · Cited by 108
Platelets as Pharmacologic Models for the Receptors and Biochemistry of Monoaminergic Neurons
Stahl, S. M. (1985) · Elsevier eBooks · doi:10.1016/b978-0-12-455555-6.50045-x · Cited by 108
NEUROPSYCHIATRIC SEQUELAE OF ACUTE EPIDEMIC ENCEPHALITIS IN CHILDREN
Ebaugh, F. G. (1923) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.1923.01920020006002 · Cited by 107
Dopamine Activates Noradrenergic Receptors in the Preoptic Area
Cornil, C. A., Balthazart, J., Motté, P., Massotte, L., & Seutin, V. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-21-09320.2002 · Cited by 107
Demarest, K. T., McKay, D. W., Riegle, G. D., & Moore, K. E. (2008) · Neuroendocrinology · doi:10.1159/000123449 · Cited by 106
Arnt, J., & Scheel‐Krüger, J. (1979) · Life Sciences · doi:10.1016/0024-3205(79)90402-8 · Cited by 106
Current drug treatments targeting dopamine D3 receptor
Leggio, G. M., Bucolo, C., Platania, C. B. M., Salomone, S., & Drago, F. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.06.007 · Cited by 105
Romanò, N., Yip, S. H., Hodson, D. J., Guillou, A., Parnaudeau, S., Kirk, S. E., Tronche, F., Bonnefont, X., Tissier, P. L., Bunn, S. J., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.4415-12.2013 · Cited by 104
Desdouits, F., Siciliano, J. C., Greengard, P., & Girault, J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.2682 · Cited by 104
Therapy development in Huntington disease: From current strategies to emerging opportunities
Dickey, A. S., & Spada, A. R. L. (2017) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.38494 · Cited by 103
Neuroanatomical Study of the A11 Diencephalospinal Pathway in the Non-Human Primate
Barraud, Q., Obeid, I., Aubert, I., Barrière, G., Contamin, H., McGuire, S., Ravenscroft, P., Porras, G., Tison, F., Bézard, E., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013306 · Cited by 102
Cahill, E., Salery, M., Vanhoutte, P., & Caboche, J. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00172 · Cited by 102
D5 Dopamine Receptors are Required for Dopaminergic Activation of Phospholipase C
Sahu, A., Tyeryar, K. R., Vongtau, H. O., Sibley, D. R., & Undieh, A. S. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.053017 · Cited by 101
Stern, J. M., & Taylor, L. A. (1991) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.1991.tb00323.x · Cited by 99
Harrington, K. A., Augood, S. J., Kingsbury, A. E., Föster, O., & Emson, P. C. (1996) · Molecular Brain Research · doi:10.1016/0169-328x(95)00278-z · Cited by 98
Genes associated with Parkinson's disease: regulation of autophagy and beyond
Beilina, A. G., & Cookson, M. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13266 · Cited by 98
Association of Norepinephrine Transporter Gene With Methylphenidate Response
Yang, L., Wang, Y., Li, J., & Faraone, S. V. (2004) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000131134.63368.46 · Cited by 97
Sleep deprivation stimulates serotonin release in the suprachiasmatic nucleus
Grossman, G., Mistlberger, R. E., Antle, M. C., Ehlen, J. C., & Glass, J. D. (2000) · Neuroreport · doi:10.1097/00001756-200006260-00024 · Cited by 96
Citrome, L. (2013) · CNS Drugs · doi:10.1007/s40263-013-0105-7 · Cited by 94
Li, Y.-C., Xi, D., Roman, J., Huang, Y.-Q., & Gao, W. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.3336-09.2009 · Cited by 93
Distribution of G-protein-coupled receptor kinase (GRK) isoforms 2, 3, 5 and 6 mRNA in the rat brain
Erdtmann-Vourliotis, M., Mayer, P. E., Ammon, S., Riechert, U., & Höllt, V. (2001) · Molecular Brain Research · doi:10.1016/s0006-8993(01)03046-3 · Cited by 93
Elucidation of G-protein and β-arrestin functional selectivity at the dopamine D2 receptor
Peterson, S. M., Pack, T. F., Wilkins, A. D., Urs, N. M., Urban, D. J., Bass, C. E., Lichtarge, O., & Caron, M. G. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1502742112 · Cited by 91
Cytochrome P450 mediates dopamine formation in the brainin vivo
Bromek, E., Haduch, A., Gołembiowska, K., & Daniel, W. A. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07339.x · Cited by 91
Identification of brain neurons expressing the dopamine D4 receptor gene using BAC transgenic mice
Noaín, D., Avale, M. E., Wedemeyer, C., Calvo, D. J., Peper, M., & Rubinstein, M. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.05148.x · Cited by 91
Henry, D. J., Hu, X., & White, F. (1998) · Psychopharmacology · doi:10.1007/s002130050762 · Cited by 90
Aguirre, P., Urrutia, P. J., Tapia, V., Villa, M., Paris, I. B., Segura‐Aguilar, J., & Núñez, M. T. (2012) · BioMetals · doi:10.1007/s10534-012-9525-y · Cited by 89
Swift, J. L., Godin, A. G., Doré, K., Freland, L., Bouchard, N., Nimmo, C. M., Sergeev, M., Koninck, Y. D., Wiseman, P. W., & Beaulieu, J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018280108 · Cited by 89
Flores-Barrera, E., Thomases, D. R., Heng, L., Cass, D. K., Caballero, A. C., & Tseng, K. Y. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.07.033 · Cited by 88
G Protein-Mediated Mitogen-Activated Protein Kinase Activation by Two Dopamine D2 Receptors
Choi, E.-Y., Jeong, D.-W., Park, K. W., & Baik, J. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0286 · Cited by 84
Chen, J., Song, J., Yuan, P., Tian, Q., Ji, Y., Ren‐Patterson, R. F., Liu, G., Sei, Y., & Weinberger, D. R. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.262790 · Cited by 84
Activation of Microtubule‐Associated Protein Kinase (Erk) and p70 S6 Kinase by D2 Dopamine Receptors
Welsh, G. I., Hall, D. A., Warnes, A., Strange, P. G., & Proud, C. G. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70052139.x · Cited by 83
Demarest, K. T., Riegle, G. D., & Moore, K. E. (2008) · Neuroendocrinology · doi:10.1159/000123935 · Cited by 82
Loughlin, S. E., & Fallon, J. H. (1983) · Brain Research · doi:10.1016/0006-8993(83)91029-6 · Cited by 82
The roles of accumbal dopamine D1 and D2 receptors in maternal memory in rats.
Parada, M., King, S., Li, M., & Fleming, A. S. (2008) · Behavioral Neuroscience · doi:10.1037/0735-7044.122.2.368 · Cited by 82
Li, C., Chen, P., & Smith, M. S. (1999) · Endocrinology · doi:10.1210/endo.140.1.6437 · Cited by 81
Croissant, J. G., Qi, C., Maynadier, M., Cattoën, X., Man, M. W. C., Raehm, L., Mongin, O., Blanchard-Desce, M. H., Garcia, M., Gary‐Bobo, M., et al. (2016) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2016.00001 · Cited by 80
Attention Deficit Hyperactivity Disorder
Matthews, M., Nigg, J. T., & Fair, D. A. (2013) · Current topics in behavioral neurosciences · doi:10.1007/7854_2013_249 · Cited by 80
Carboni, E., Silvagni, A., Vacca, C., & Chiara, G. D. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03556.x · Cited by 78
Dopamine Reuptake by Norepinephrine Neurons: Exception or Rule?
Carboni, E., & Silvagni, A. (2004) · Critical Reviews in Neurobiology · doi:10.1615/critrevneurobiol.v16.i12.130 · Cited by 77
Gardner, B., Hall, D. A., & Strange, P. G. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15572.x · Cited by 76
Does monoamine oxidase type B play a role in dopaminergic nerve cell death in Parkinson's disease?
Damier, P., Kästner, A., Agid, Y., & Hirsch, É. C. (1996) · Neurology · doi:10.1212/wnl.46.5.1262 · Cited by 76
Arbogast, L. A., & Voogt, J. L. (1996) · Endocrinology · doi:10.1210/endo.137.1.8536641 · Cited by 76
Exploring the Correlates of Intermediate CAG Repeats in Huntington Disease
Ha, A. D., & Jankovic, J. J. (2011) · Postgraduate Medicine · doi:10.3810/pgm.2011.09.2466 · Cited by 75
Kim, S., Kim, M. Y., Lee, E. J., Ahn, Y. S., & Baik, J. (2003) · Molecular Endocrinology · doi:10.1210/me.2003-0066 · Cited by 75
Park, S. M., Chen, M., Schmerberg, C. M., Dulman, R. S., Rodriguiz, R. M., Caron, M. G., Jin, J. J., & Wetsel, W. C. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.196 · Cited by 74
de la Escalera, G. M., & Weiner, R. I. (1992) · Endocrine Reviews · doi:10.1210/edrv-13-2-241 · Cited by 73
Impaired light masking in dopamine D2 receptor–null mice
Doi, M., Yujnovsky, I., Hirayama, J., Malerba, M., Tirotta, E., Sassone‐Corsi, P., & Borrelli, E. (2006) · Nature Neuroscience · doi:10.1038/nn1711 · Cited by 71
The Origin and Evolution of G Protein-Coupled Receptor Kinases
Mushegian, A. R., Gurevich, V. V., & Gurevich, E. V. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033806 · Cited by 68
Veselinović, T., Paulzen, M., & Gründer, G. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2013.853448 · Cited by 67
Origin of the dopaminergic innervation of the rat dorsal raphe nucleus
Peyron, C., Luppi, P., Kitahama, K., Fort, P., Hermann, D. M., & Jouvet, M. (1995) · Neuroreport · doi:10.1097/00001756-199512150-00019 · Cited by 67
Dissociation of Prolactin Secretion from Tuberoinfundibular Dopamine Activity in Late Pregnant Rats
Andrews, Z. B., Kokay, I. C., & Grattan, D. R. (2001) · Endocrinology · doi:10.1210/endo.142.6.8196 · Cited by 67
Seeman, P. M., Ko, F., Jack, E., Greenstein, R., & Dean, B. (2007) · Synapse · doi:10.1002/syn.20368 · Cited by 66
CASK and CaMKII function in the mushroom body α′/β′ neurons during Drosophila memory formation
Malik, B. R., Gillespie, J. M., & Hodge, J. J. L. (2013) · Frontiers in Neural Circuits · doi:10.3389/fncir.2013.00052 · Cited by 66
Tanda, G., Frau, R., & Chiara, G. D. (1995) · Psychopharmacology · doi:10.1007/bf02246048 · Cited by 65
Li, L., Homan, K. T., Vishnivetskiy, S. A., Manglik, A., Tesmer, J. J. G., Gurevich, V. V., & Gurevich, E. V. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.644773 · Cited by 65
Pan, W. H. T., Yang, S., & Lin, S. (2004) · Synapse · doi:10.1002/syn.20034 · Cited by 64
Dopamine enhances motor and neuropathological consequences of polyglutamine expanded huntingtin
Cyr, M., Sotnikova, T. D., Gainetdinov, R. R., & Caron, M. G. (2006) · The FASEB Journal · doi:10.1096/fj.06-6533fje · Cited by 64
Williams‐Gray, C. H., & Worth, P. F. (2016) · Medicine · doi:10.1016/j.mpmed.2016.06.001 · Cited by 64
Sams‐Dodd, F. (1998) · Psychopharmacology · doi:10.1007/s002130050500 · Cited by 63
Silvano, E., Millan, M. J., la Cour, C. M., Han, Y., Duan, L., Griffin, S. A., Luedtke, R. R., Aloisi, G., Rossi, M., Zazzeroni, F., et al. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.065755 · Cited by 63
alpha2C adrenoceptors inhibit adenylyl cyclase in mouse striatum: potential activation by dopamine.
Zhang, W., Klimek, V., Farley, J. T., Zhu, M., & Ordway, G. A. (1999) · PubMed · Cited by 63
Potency of catecholamines and other l-tyrosine derivatives at the cloned mouse adrenergic receptors
Zhang, W., Ouyang, M., & THOMAS, S. A. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.04.017 · Cited by 62
Chapter 12 Regulation of prolactin secretion during pregnancy and lactation
Voogt, J. L., Lee, Y., Yang, S., & Arbogast, L. A. (2001) · Progress in brain research · doi:10.1016/s0079-6123(01)33013-3 · Cited by 61
Dopamine, hypertension and obesity
Contreras, F., Fouillioux, C., Bolívar, A., Simonovis, N., Hernández-Hernández, R., Armas-Hernández, M. J., & Velasco, M. (2002) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001334 · Cited by 61
Otmakhova, N. A., Düzel, E., Deutch, A. Y., & Lisman, J. E. (2012) · Springer eBooks · doi:10.1007/978-3-642-32375-1_10 · Cited by 59
Neuroreceptor imaging in psychiatric disorders
Frankle, W. G., & Laruelle, M. A. (2002) · Annals of Nuclear Medicine · doi:10.1007/bf02988639 · Cited by 58
A morphometric evidence for a hyperfunctioning mesolimbic system in an animal model of ADHD
Viggiano, D., Grammatikopoulos, G., & Sadile, A. G. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00423-5 · Cited by 58
Dopamine D2 receptor Taq IA polymorphism is associated with postoperative nausea and vomiting
Nakagawa, M., Kuri, M., Kambara, N., Tanigami, H., Tanaka, H., Kishi, Y., & Hamajima, N. (2008) · Journal of Anesthesia · doi:10.1007/s00540-008-0661-z · Cited by 56
Regulation of the Pcl7–Pho85 cyclin–cdk complex by Pho81
Lee, M., O'regan, S., Moreau, J. ‐., Johnson, A. L., Johnston, L. H., & Goding, C. R. (2000) · Molecular Microbiology · doi:10.1046/j.1365-2958.2000.02140.x · Cited by 54
Michael-Titus, A. T., Bousselmame, R., & Costentin, J. (1990) · European Journal of Pharmacology · doi:10.1016/0014-2999(90)90007-s · Cited by 54
Heterologous monoamine reuptake: lack of transmitter specificity of neuron-specific carriers.
Chiara, G. D., Tanda, G., Frau, R., & Carboni, E. (1992) · PubMed · Cited by 53
Stolzenberg, D. S., Zhang, K. Y., Luskin, K. A., Ranker, L. R., Bress, J. N., & Numan, M. (2009) · Hormones and Behavior · doi:10.1016/j.yhbeh.2009.09.014 · Cited by 53
Molecular Imaging Studies in Parkinson Disease
Felicio, A. C., Shih, M. C., Godeiro-Junior, C. D. O., Andrade, L. E. C., Bressan, R. A., & Ferraz, H. B. (2009) · The Neurologist · doi:10.1097/nrl.0b013e318183fdd8 · Cited by 53
Dopamine receptor signaling molecules are altered in elderly schizophrenic cortex
Baracskay, K. L., Haroutunian, V. H., & Meador‐Woodruff, J. H. (2006) · Synapse · doi:10.1002/syn.20292 · Cited by 53
Homovanillic acid in CSF of mild stage Parkinson's disease patients correlates with motor impairment
Stefani, A., Pierantozzi, M., Olivola, E., Galati, S., Cerroni, R., D’Angelo, V., Hainsworth, A. H., Saviozzi, V., Fedele, E., & Liguori, C. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.01.007 · Cited by 53
Flagged first, then by citations
Research works printed but not linked: 4
- Dale H (1935) Pharmacology and nerve-endings: Walter Ernest Dixon Memorial Lecture. Proc R Soc Med 28:319–332
- Faraone SV, Sergeant J, Gillberg C, Biederman J (2003) The worldwide prevalence of ADHD: is it an American condition? World Psychiatry 2:104
- Hohman LB (1922) Post-encephalitic behavior disorders in children. Johns Hopkins Hospt Bull 33:372–375
- Stryker S (1925) Encephalitis lethargica—the behavior residuals. Train Sch Bull (Vinel) 22:152–157
Cited by
Sorted by citations
Teleanu, R. I., Niculescu, A.-G., Roza, E., Vladâcenco, O. A., Grumezescu, A. M., & Teleanu, D. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23115954 · Cited by 659
Next-generation GRAB sensors for monitoring dopaminergic activity in vivo
Sun, F., Zhou, J., Dai, B., Qian, T., Zeng, J., Li, X., Zhuo, Y., Zhang, Y., Wang, Y., Cheng, Q., et al. (2020) · Nature Methods · doi:10.1038/s41592-020-00981-9 · Cited by 483
Dopamine in Parkinson's disease
Latif, S., Jahangeer, M., Razia, D. E. M., Ashiq, M., Ghaffar, A., Akram, M., Allam, A. E., Bouyahya, A., Garipova, L., Shariati, M. A., et al. (2021) · Clinica Chimica Acta · doi:10.1016/j.cca.2021.08.009 · Cited by 374
Berk, M., Köhler‐Forsberg, O., Turner, M., Penninx, B. W. J. H., Wrobel, A., Firth, J., Loughman, A., Reavley, N. J., McGrath, J. J., Momen, N. C., et al. (2023) · World Psychiatry · doi:10.1002/wps.21110 · Cited by 336
Electrochemical Biosensing of Dopamine Neurotransmitter: A Review
Lakard, S., Pavel, I., & Lakard, B. (2021) · Biosensors · doi:10.3390/bios11060179 · Cited by 245
Metadata
- Authors
- Klein, M. O., Battagello, D. S., Cardoso, A. R., Hauser, D. N., Bittencourt, J. C., & Correa, R. G.
- Affiliations
- Universidade de São Paulo (BR)
- Sanford Burnham Prebys Medical Discovery Institute (US)
- Corresponding author
- Bittencourt, Jackson C.
- Correa, Ricardo G.
- ORCID
- Venue
- Cellular and Molecular Neurobiology
- Published
- 2018-11-16
- Volume
- 39
- Issue
- 1
- Pages
- 31-59
- ISSN
- 0272-4340 (ISSN-L)
- 1573-6830
- PMC
- PMC11469830
- OpenAlex
- W2901208536
- Cited by
- 1,073
- References
- 472
- Citations by year
- 2026: 141 · 2025: 174 · 2024: 214 · 2023: 199 · 2022: 148 · 2021: 105 · 2020: 64 · 2019: 27
- FWCI
- 6.41
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Cellular and Molecular Neurobiology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- dopamine, dopaminergic signaling, dopamine receptors, G protein-coupled receptors, catecholamine neurotransmitters, neuromodulation, neurodegenerative diseases, Parkinson's disease, schizophrenia, Huntington's disease, attention deficit hyperactivity disorder, addiction, dopaminergic therapy, reward and motivation
- MeSH terms
- Animals, Brain, Dopamine, Humans, Models, Biological, Nervous System Diseases, Signal Transduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review